Issue 000 | U.S. Pilot | US

LIANY

LianBio

Needs Review Stale Filing 10-Q | 2023-11-13 Filing currency: USD
Margin of Safety 94.7%

GNNI internal calculation. Market context inputs are retained internally and are not displayed.

Current Assets
257,805,000USD
Total Liabilities
26,790,000USD
NCAV
231,015,000USD
Cash
103,457,000USD
NCAV per share
2.16USD/share
Evidence
2 annual | 8 quarterly

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible.

Business profile not generated.

Run python -m application.cli.business_profile run --market US --one LIANY, then regenerate the site.

Known Unknowns

Only 8 quarterly periods available from Data Vault for this company.

Medium | Share Count

Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Medium | Filing

Some rows are based on older filing data and require manual freshness review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue n/a n/a
Operating Income -125,353,000 -195,570,000
Net Income -110,290,000 -196,300,000
Cash From Operations -99,185,000 -163,953,000
Capex -1,845,000 -947,000
Free Cash Flow -101,030,000 -164,900,000
Cash And Equivalents 79,221,000 228,182,000
Accounts Receivable n/a n/a
Inventory n/a n/a
Total Current Assets 312,773,000 399,647,000
Total Assets 319,960,000 426,343,000
Total Current Liabilities 23,615,000 15,092,000
Total Liabilities 26,313,000 39,007,000
Shareholders Equity 259,873,000 353,562,000
Shares Outstanding 107,043,924 107,275,458
Shares Outstanding Diluted n/a n/a
Weighted Avg Shares Diluted 107,923,296 34,394,622
Weighted Avg Shares Basic 107,923,296 34,394,622
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 8 quarterly periods available from Data Vault for this company.

Metric
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-09-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -26,301,000 -25,044,000 -25,969,000 -29,245,000 -24,549,000 -43,142,000 -28,417,000 n/a
Net Income -24,039,000 -21,621,000 -24,045,000 -18,276,000 -21,897,000 -42,391,000 -27,726,000 n/a
Cash From Operations -15,864,000 -19,318,000 -17,632,000 -30,713,000 -15,964,000 -39,407,000 -13,101,000 n/a
Capex -160,000 -50,000 -19,000 -235,000 -937,000 -329,000 -344,000 n/a
Free Cash Flow -16,024,000 -19,368,000 -17,651,000 -30,948,000 -16,901,000 -39,736,000 -13,445,000 n/a
Cash And Equivalents 103,457,000 104,059,000 102,334,000 79,221,000 78,862,000 134,334,000 139,857,000 109,015,000
Total Current Assets 257,805,000 273,098,000 296,050,000 312,773,000 324,238,000 343,704,000 386,136,000 121,003,000
Total Liabilities 26,790,000 23,293,000 28,156,000 26,313,000 45,244,000 45,615,000 48,706,000 42,259,000
Shares Outstanding 107,168,686 107,167,609 107,164,175 107,043,924 108,353,831 108,353,831 107,275,458 21,787,245
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 107,167,691 107,164,401 107,162,025 107,923,296 108,353,831 107,922,501 107,275,458 20,690,908
Weighted Avg Shares Basic 107,167,691 107,164,401 107,162,025 107,923,296 108,353,831 107,922,501 107,275,458 20,690,908
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 257,805,000USD us-gaap:AssetsCurrent 2023-09-30 1.00 sec/companyfacts/cik=0001831283/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
Total Liabilities 26,790,000USD us-gaap:Liabilities 2023-09-30 1.00 sec/companyfacts/cik=0001831283/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
Cash 103,457,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2023-09-30 1.00 sec/companyfacts/cik=0001831283/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
Shares Outstanding 107,168,686 us-gaap:CommonStockSharesOutstanding 2023-09-30 1.00 sec/companyfacts/cik=0001831283/companyfacts.json
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
NCAV 231,015,000USD derived 2023-09-30 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.16USD derived 2023-09-30 n/a company-evidence-v1 | NCAV / shares_outstanding
Margin of Safety 94.7% derived 2023-09-30 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
D:\Projects\The Data Vault
CIK
0001831283
Company ID
n/a
Selected Annual Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
Selected Quarterly Source
D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001831283\companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
10
Imported At
2026-07-04T23:04:33+00:00
Rendered At
2026-07-05T09:06:29+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001831283-23-000126
CIK
0001831283
Mary Filing Date
2023-11-13
Filing Currency
USD
Internal Discount
94.7%
Source State
Stale Filing
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2023-11-13; mary_accession=0001831283-23-000126; mary_cik=0001831283; gnni_supporting_filing_date=2023-11-13; internal_discount=0.946651; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review

Back to Register Archive